Kimberly Nellenbach

Director Translational Clinical Development
SelSym Biotech, United States

Presentation(s):

• A vascular microphysiological system with a defined injury and coagulation site

  Thursday, October 12, 2023
  3:45 PM - 4:00 PM PDT

• Clot-targeted nanogels for anticoagulant and fibrinolytic dual-delivery to treat disseminated intravascular coagulation

  Saturday, October 14, 2023
  8:30 AM - 8:45 AM PDT